Prospective Clinical Assessment Study in Children with Achondroplasia: The PROPEL Trial
Details
Age
Child
Eligibility
Aged 2.5 <17years, diagnosis of ACH, ambulatory and able to stand without assistance, and participant, parent, or legally authorized representative willing and able to comply with study visits and procedures.
Type of Study
Observational
Scope
National
Locations
Childrens Hospital Colorado
Principal Investigator
Klane White, MD, MSc
Study ID
Protocol Number: 23-0416
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers